Ready to Engage

Recent events have brought to a head Europe's discord over the practice of parallel trade. Opinions on its value are diametrically opposed, with some condemning it as a danger to patients and others asserting that it generates savings for healthcare systems. A key point of current debate, however, is whether it lets criminal counterfeiters into the supply chain

The argument against parallel trade
Some feel that parallel trade weakens security, enabling drug counterfeiters to enter and pollute legitimate supply chains
Read more

The argument for parallel trade
others believe that today's well-regulated parallel trade creates much-needed savings for europe's healthcare systems
Read more

Pharma speaks out
glaxosmithkline has recently experienced victory over parallel traders in greek courts - Alice Hunt talks about the outcomes
Read more